Anti-inflammatory liaisons: T regulatory cells and HDL1

Anti-inflammatory liaisons: T regulatory cells and HDL1

Bibliographic Details
Main Authors:	Mary G. Sorci-Thomas, Michael J. Thomas
Format:	Article
Language:	English
Published:	Elsevier 2017-08-01
Series:	Journal of Lipid Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520337767

Similar Items

Three-dimensional models of HDL apoA-I: implications for its assembly and function*
by: Michael J. Thomas, et al.
Published: (2008-09-01)

HDL and electronegative LDL exchange anti- and pro-inflammatory properties
by: Cristina Bancells, et al.
Published: (2010-10-01)

Preparation and incorporation of probe-labeled apoA-I for fluorescence resonance energy transfer studies of rHDL
by: Hui-hua Li, et al.
Published: (2001-12-01)

Anti-Inflammatory Effects of HDL in Mice With Rheumatoid Arthritis Induced by Collagen
by: Yunlong Wang, et al.
Published: (2018-05-01)

The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation
by: Sanam Ebtehaj, et al.
Published: (2017-10-01)

The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties[S]
by: Anna Schwendeman, et al.
Published: (2015-09-01)

SAA: a link between cholesterol efflux capacity and inflammation?1
by: Michael J. Thomas, et al.
Published: (2015-08-01)

The metabolism and anti-atherogenic properties of HDL
by: Kerry-Anne Rye, et al.
Published: (2009-01-01)

Decreased Regulatory T Cells in Vulnerable Atherosclerotic Lesions: Imbalance between Pro- and Anti-Inflammatory Cells in Atherosclerosis
by: Ilonka Rohm, et al.
Published: (2015-01-01)

S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization
by: Mi-Hye Lee, et al.
Published: (2017-02-01)

Activation de liaisons C-O catalysée par le nickel et sulfénylation de liaisons C-H
by: Hostier, Thomas
Published: (2016)

Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo
by: Tetsuya Hara, et al.
Published: (2011-01-01)

Construction of an inflammatory microenvironment-responsive HDL-mimetic nanoparticle and evaluation of its in vitro anti-atherosclerotic activity
by: LIU Renfeng, et al.
Published: (2020-06-01)

Locke : liaison probable et liaison nécessaire
by: Éric Marquer
Published: (2014-06-01)

The mRNA expression of pro- and anti-inflammatory cytokines in T regulatory cells in children with type 1 diabetes.
by: Maria Górska, et al.
Published: (2010-06-01)

PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity
by: Daoguang Yan, et al.
Published: (2004-10-01)

Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL[S]
by: Hagai Tavori, et al.
Published: (2015-03-01)

Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity[S]
by: Tomáš Vaisar, et al.
Published: (2015-08-01)

HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases
by: Fabrizia Bonacina, et al.
Published: (2021-04-01)

HDL interfere with the binding of T cell microparticles to human monocytes to inhibit pro-inflammatory cytokine production.
by: Rakel Carpintero, et al.
Published: (2010-07-01)

An Injectable Hydrogel Platform for Sustained Delivery of Anti-inflammatory Nanocarriers and Induction of Regulatory T Cells in Atherosclerosis
by: Sijia Yi, et al.
Published: (2020-06-01)

Dangerous Liaisons?
by: Norman L Jones
Published: (2000-01-01)

Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer’s Disease: A Narrative Review
by: Francesca Zimetti, et al.
Published: (2021-01-01)

The ins and outs of lipid rafts: functions in intracellular cholesterol homeostasis, microparticles, and cell membranes
by: Amber B. Ouweneel, et al.
Published: (2020-05-01)

The Effects of Anti-inflammatory Drugs on Proliferation and the Regulatory Factors of Cell Cycle in Human Osteoblas
by: Ching-Ju Li, et al.
Published: (2004)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
by: Giovanni Cioffi, et al.
Published: (2021-03-01)

Anti-regulatory T cells are natural regulatory effector T cells
by: Niels Ødum
Published: (2019-10-01)

HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL
by: Navab Kaveh, et al.
Published: (2011-02-01)

Complete intersection liaison and Gorenstein liaison: new results and open problems
by: Rosa Maria Mirò-Roig
Published: (2000-09-01)

There is No Association Between Subject Liaisons’ Perception of Their Work and Faculty Satisfaction with Their Liaisons
by: Lisa Shen
Published: (2013-12-01)

Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI
by: Thomas J.F. Nieland, et al.
Published: (2007-08-01)

Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity[S]
by: Nathalie Pamir, et al.
Published: (2019-03-01)

In vivo conversion of human HDL3 to HDL2 and apoE-rich HDL1 in the rat: effects of lipid transfer protein.
by: D Gavish, et al.
Published: (1987-03-01)

Visualizing caveolin-1 and HDL in cholesterol-loaded aortic endothelial cells
by: W.T. Chao, et al.
Published: (2003-06-01)

New insights into the determination of HDL structure by apolipoproteins1
by: Michael C. Phillips
Published: (2013-08-01)

Reliability of the chemiluminescence Liaison Treponema Screen test for the screening of anti-Treponema antibodies
by: Nicoletta Rusconi, et al.
Published: (2011-09-01)

Experiments with the Gorenstein liaison
by: Robin Hartshorne
Published: (2000-09-01)

Consultation liaison with nephrology
by: Neena S Sawant
Published: (2018-01-01)

Anti-Inflammatory and Immune Regulatory Actions of Naja naja atra Venom
by: Shu-Zhi Wang, et al.
Published: (2018-02-01)

Enhanced HDL-cholesterol-associated anti-oxidant PON-1 activity in prostate cancer patients
by: Muzaffer Eroglu, et al.
Published: (2013-07-01)